Serina Therapeutics Inc.
Organization details
- Legal name
- Serina Therapeutics Inc.
- Former names
- AgeX Therapeutics, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Alabama
- Headquarters city
- Huntsville
- Headquarters state / province
- Alabama
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SER
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001708599
- EIN
- 82-1436829
Board of directors
-
Farrell Simon · DirectorSince 2026
-
Gregory Bailey · DirectorSince 2024
-
J. Milton Harris · DirectorSince 2024
-
Jay Venkatesan · DirectorSince 2025
-
Jean-Christophe Renondin · DirectorSince 2023
-
Karen J. Wilson · DirectorSince 2025
-
Remy Gross · DirectorSince 2024
-
Richard Peter Marshall · DirectorSince 2024
-
Simba Gill · DirectorSince 2024
-
Stephen K. Brannan · DirectorSince 2025
-
Steven A. Ledger · Director · Chief Executive OfficerSince 2024
-
Steven Mintz · DirectorSince 2024
Chief executives
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 0
-79.7% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Director election results
Annual meeting of June 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.3%
-
98.4%
-
99.7%
Board connections
4 of this board's directors also sit on 4 other boards. 4 are in the same sector.
-
Elicio Therapeutics Inc. Same sectorvia Jay Venkatesan and Karen J. Wilson
-
Biohaven Ltd. Same sectorvia Gregory Bailey
-
Connect Biopharma Holdings Limited Same sectorvia Karen J. Wilson
-
Foghorn Therapeutics Inc. Same sectorvia Simba Gill
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $77,955
- 7 purchases by 4 insiders
- Sold, last 12 months
- $359,502
- 22 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 2026 | Stephen K. Brannan Director | Open-market purchase | +1,000 | $2.03 | $2,030 |
| Jun 17, 2026 | Gregory Bailey Director | Derivative conversion | +1,770,805 | $2.25 | $3,984,311 |
| Jun 17, 2026 | Jay Venkatesan Director | Derivative conversion | +224,152 | $2.25 | $504,342 |
| Jun 17, 2026 | Gregory Bailey Director | Derivative conversion | +6,666,667 | $2.25 | $15,000,001 |
| Jun 12, 2026 | Karen J. Wilson Director | Open-market purchase | +5,000 | $1.77 | $8,850 |
| Jun 11, 2026 | Karen J. Wilson Director | Open-market purchase | +5,100 | $1.75 | $8,925 |
| May 26, 2026 | Steven A. Ledger Director, Officer (Chief Executive Officer) | Grant or award | +10,100 | $1.93 | $19,493 |
| May 22, 2026 | Jay Venkatesan Director | Open-market purchase | +589 | $1.78 | $1,048 |
| May 22, 2026 | Karen J. Wilson Director | Open-market purchase | +10,000 | $1.93 | $19,300 |
| May 21, 2026 | Karen J. Wilson Director | Open-market purchase | +10,000 | $1.77 | $17,700 |
| May 19, 2026 | Richard Peter Marshall Director | Open-market purchase | +12,183 | $1.65 | $20,102 |
| Mar 31, 2026 | Gregory Bailey Director | Grant or award | +59,667 | $1.94 | $115,754 |
| Mar 31, 2026 | Jay Venkatesan Director | Grant or award | +7,553 | $1.94 | $14,653 |
| Mar 23, 2026 | Moreadith Randall Officer (Chief Scientific Officer) | Option exercise | +6,500 | $0.06 | $390 |
| Mar 23, 2026 | Moreadith Randall Officer (Chief Scientific Officer) | Open-market sale | −6,500 | $2.86 | $18,590 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Serina Therapeutics Inc.
Who is the CEO of Serina Therapeutics Inc.?
Steven A. Ledger has been Serina Therapeutics Inc.'s Interim CEO since March 2024.
How many directors are on Serina Therapeutics Inc.'s board?
Serina Therapeutics Inc.'s board has 12 directors: Farrell Simon, Gregory Bailey, J. Milton Harris, Jay Venkatesan, Jean-Christophe Renondin, Karen J. Wilson, Remy Gross, Richard Peter Marshall, Simba Gill, Stephen K. Brannan and 2 others.
Are Serina Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Serina Therapeutics Inc. insiders bought $77,955 of shares in 7 purchases and sold $359,502 of shares in 22 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="serina-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.